{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:14:19Z","timestamp":1773296059677,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R43AI085783"],"award-info":[{"award-number":["R43AI085783"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R43AG042993"],"award-info":[{"award-number":["R43AG042993"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T08:22:28Z","timestamp":1452759748000},"page":"887-892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, r Ov -ASP-1"],"prefix":"10.1016","volume":"34","author":[{"given":"Jiu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Concannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lustigman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna M.","family":"Murasko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2016.01.003_bib0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918\u20131920 Spanish influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull Hist Med"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.003_bib0260","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ni1530","article-title":"Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic","volume":"8","author":"Ahmed","year":"2007","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.003_bib0265","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0047-6374(02)00010-6","article-title":"Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection","volume":"123","author":"Po","year":"2002","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.003_bib0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/icb.2013.77","article-title":"How T follicular helper cells and the germinal centre response change with age","volume":"92","author":"Linterman","year":"2014","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.003_bib0275","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.003_bib0280","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.vaccine.2009.10.045","article-title":"Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis","volume":"28","author":"Velez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.003_bib0285","first-page":"307","article-title":"Immunization against influenza with observations during an epidemic of influenza A one year after vaccination","volume":"42","author":"Salk","year":"1945","journal-title":"Am J Hyg"},{"issue":"RR-13","key":"10.1016\/j.vaccine.2016.01.003_bib0290","first-page":"1","article-title":"Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"52","author":"Harper","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.003_bib0295","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.003_bib0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0264-410X(86)80002-0","article-title":"Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports","volume":"4","author":"Strassburg","year":"1986","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2016.01.003_bib0305","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1994.03520210045030","article-title":"The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial","volume":"272","author":"Govaert","year":"1994","journal-title":"JAMA"},{"issue":"RR-8","key":"10.1016\/j.vaccine.2016.01.003_bib0310","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"21","key":"10.1016\/j.vaccine.2016.01.003_bib0315","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2013.09.074","article-title":"Immunogenicity and safety of Fluzone(R) intradermal and high-dose influenza vaccines in older adults\u226565 years of age: a randomized, controlled, phase II trial","volume":"32","author":"Tsang","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.003_bib0320","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(14)71087-4","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis","volume":"15","author":"Izurieta","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2016.01.003_bib0325","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/CVI.00035-11","article-title":"Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant","volume":"18","author":"Hamouda","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.003_bib0330","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2007.11.003","article-title":"How do adjuvants work? Important considerations for new generation adjuvants","volume":"27","author":"McKee","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.003_bib0335","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants\u2014a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.003_bib0340","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nm.2306","article-title":"Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity","volume":"17","author":"Flach","year":"2011","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.003_bib0345","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.100.5.1139","article-title":"Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man","volume":"100","author":"Davenport","year":"1968","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.003_bib0350","first-page":"283","article-title":"Comparison of anti-influenza vaccines: whole adsorbed trivalent, trivalent subunit and tetravalent subunit","volume":"67","author":"D\u2019Errico","year":"1988","journal-title":"Boll Ist Sieroter Milan"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.003_bib0355","first-page":"265","article-title":"Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I.","volume":"48","author":"Ionita","year":"1989","journal-title":"Arch Roum Pathol Exp Microbiol"},{"issue":"25","key":"10.1016\/j.vaccine.2016.01.003_bib0360","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1016\/j.vaccine.2005.01.080","article-title":"Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults","volume":"23","author":"McElhaney","year":"2005","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2016.01.003_bib0365","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.vaccine.2008.07.028","article-title":"Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines","volume":"26","author":"Xiao","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2016.01.003_bib0370","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.4049\/jimmunol.0800531","article-title":"Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells","volume":"182","author":"He","year":"2009","journal-title":"J Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2016.01.003_bib0375","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.vaccine.2014.03.046","article-title":"Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines","volume":"32","author":"Jiang","year":"2014","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2016.01.003_bib0380","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1016\/j.vaccine.2010.08.049","article-title":"Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant","volume":"28","author":"Zhao","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.003_bib0385","doi-asserted-by":"crossref","first-page":"e37019","DOI":"10.1371\/journal.pone.0037019","article-title":"The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.003_bib0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0166-6851(00)00231-0","article-title":"Angiogenic activity of Onchocerca volvulus recombinant proteins similar to vespid venom antigen 5","volume":"109","author":"Tawe","year":"2000","journal-title":"Mol Biochem Parasitol"},{"issue":"26","key":"10.1016\/j.vaccine.2016.01.003_bib0395","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.vaccine.2005.01.098","article-title":"rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens","volume":"23","author":"MacDonald","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.003_bib0400","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0141-9838.2004.00685.x","article-title":"Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity","volume":"26","author":"MacDonald","year":"2004","journal-title":"Parasite Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2016.01.003_bib0405","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.1128\/JVI.00159-10","article-title":"Adaptation of pandemic H1N1 influenza viruses in mice","volume":"84","author":"Ilyushina","year":"2010","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2016.01.003_bib0410","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.vaccine.2008.02.063","article-title":"Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection","volume":"26","author":"Bungener","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.003_bib0415","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00395856","article-title":"The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes","volume":"29","author":"Jouvin-Marche","year":"1989","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.003_bib0420","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Martin","year":"1998","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.003_bib0425","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)01357-5","article-title":"Importance of IgG2c isotype in the immune response to beta-amyloid in amyloid precursor protein\/transgenic mice","volume":"338","author":"Petrushina","year":"2003","journal-title":"Neurosci lett"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.003_bib0430","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2796.2009.02201.x","article-title":"Influenza vaccines provide diminished protection but are cost-saving in older adults","volume":"267","author":"Deans","year":"2010","journal-title":"J Intern Med"},{"issue":"14","key":"10.1016\/j.vaccine.2016.01.003_bib0435","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol","year":"2007","journal-title":"N Engl J Med"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2016.01.003_bib0440","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0264-410X(02)00041-5","article-title":"A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community","volume":"20","author":"Vu","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.003_bib0445","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/323085","article-title":"Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans","volume":"184","author":"Nordin","year":"2001","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.003_bib0450","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/COH.0b013e32833d2cdb","article-title":"Role of adjuvants in modeling the immune response","volume":"5","author":"Carter","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.003_bib0455","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1567201043334597","article-title":"Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery","volume":"1","author":"Diwan","year":"2004","journal-title":"Curr Drug Delivery"},{"issue":"44-46","key":"10.1016\/j.vaccine.2016.01.003_bib0460","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2006.05.039","article-title":"Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses","volume":"24","author":"Lu","year":"2006","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2016.01.003_bib0465","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0264-410X(00)00022-0","article-title":"A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice","volume":"18","author":"Katz","year":"2000","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.003_bib0470","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0264-410X(90)90093-2","article-title":"Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes","volume":"8","author":"Mbawuike","year":"1990","journal-title":"Vaccine"},{"issue":"5995","key":"10.1016\/j.vaccine.2016.01.003_bib0475","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1126\/science.1195116","article-title":"Immunology prime, boost, and broaden","volume":"329","author":"Doms","year":"2010","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.vaccine.2016.01.003_bib0480","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.003_bib0485","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0264-410X(98)00117-0","article-title":"Immune response to influenza vaccination in a large healthy elderly population","volume":"17","author":"Bernstein","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.003_bib0490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/CIA.S25215","article-title":"Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence","volume":"7","author":"Lang","year":"2012","journal-title":"Clin Interv Aging"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2016.01.003_bib0495","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0531-5565(01)00210-8","article-title":"Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly","volume":"37","author":"Murasko","year":"2002","journal-title":"Exp Gerontol"},{"issue":"14","key":"10.1016\/j.vaccine.2016.01.003_bib0500","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T13:39:56Z","timestamp":1692193196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X16000220"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}